Stock analysts at Lake Street Capital began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Get Free Report) in a note issued to investors on Wednesday,Briefing.com Automated Import reports. The brokerage set a “buy” rating and a $20.00 price target on the stock. Lake Street Capital’s price objective would suggest a potential upside of 247.83% from the company’s previous close.
AVR has been the topic of a number of other reports. TD Cowen started coverage on shares of Anteris Technologies Global in a research report on Tuesday. They issued a “buy” rating and a $15.00 price objective on the stock. Cantor Fitzgerald initiated coverage on shares of Anteris Technologies Global in a report on Tuesday. They issued an “overweight” rating and a $9.00 target price on the stock. Finally, Barclays assumed coverage on shares of Anteris Technologies Global in a report on Tuesday. They set an “overweight” rating and a $22.00 price target for the company.
View Our Latest Research Report on Anteris Technologies Global
Anteris Technologies Global Stock Performance
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- 5 discounted opportunities for dividend growth investors
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
- Dividend Capture Strategy: What You Need to Know
- Cal-Maine Foods: A Defensive Play With a Cage-Free Future
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.